Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Axovant Sciences GmbhfiledCriticalAxovant Sciences Gmbh
Publication of AR104570A1publicationCriticalpatent/AR104570A1/es
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Abstract
Usos de antagonistas del receptor de 5-HT₆, específicamente altas dosis de 3-fenilsulfonil-8-piperazinil-1-il-quinolina y a la combinación de antagonistas del receptor de 5-HT₆, específicamente 3-fenilsulfonil-8-piperazinil-1-il-quinolina, con un inhibidor de acetilcolinesterasa para el tratamiento de una enfermedad neurodegenerativa. Composición farmacéutica.
ARP160101329A2015-05-072016-05-09Métodos de tratamiento de una enfermedad neurodegenerativa
AR104570A1
(es)